证券之星消息，2月2日电子化学品板块较上一交易日下跌4.11%，中巨芯领跌。当日上证指数报收于 4015.75，下跌2.48%。深证成指报收于13824.35，下跌2.69%。电子化学品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600330 | 天通股份 | 14.00 | 3.24% | 223.82万 | 31.68亿 | | 603002 | 宏昌电子 | 9.11 | -1.73% | 66.07万 | 6.15亿 | | 688150 | 莱特光电 | 27.21 | -2.23% | 6.62万 | 1.83亿 | | 300684 | 中石科技 | 55.05 | -2.27% | 9.44万 | 5.30亿 | | 301630 | 同宇新材 | 175.10 | -2.39% | 3435.0 | 6082.08万 | | 002584 | 西陇科学 | 8.75 | -2.78% | 25.53万 | 2.26亿 | | 688545 | 兴福电子 ...

Investment Rating - The report maintains a strong rating for the chemical industry, indicating a positive outlook for the sector [5]. Core Insights - The chemical sector has shown resilience with the CITIC Basic Chemical Index rising by 5.73% and the Shenwan Chemical Index increasing by 7.29% this week [13][16]. - Key sub-industries such as soda ash, chlor-alkali, and dyeing chemicals have experienced significant price increases, with soda ash rising by 13.3% [16]. - The report highlights the competitive strength of domestic tire manufacturers and suggests focusing on companies like Sailun Tire and Linglong Tire as potential growth opportunities [4]. - The polyurethane project by Huide Technology, with an annual production capacity of 600,000 tons, has commenced, indicating strategic growth in the new materials sector [3]. - The report emphasizes the tightening supply-demand dynamics in the phosphate chemical sector due to environmental regulations and increasing demand from the new energy sector [4]. Summary by Sections Market Overview - The Shanghai Composite Index increased by 0.84%, while the ChiNext Index decreased by 0.34% [13]. - The overall performance of the chemical sector is positive, with notable gains in various sub-industries [16]. Key Sub-Industry Developments - **Polyurethane**: The price of pure MDI in East China is reported at 17,600 RMB/ton, showing a week-on-week decline of 1.12% [28]. - **Tires**: The operating load for all-steel tires in Shandong is at 62.70%, reflecting a year-on-year increase of 20.70% [49]. - **Fertilizers**: Urea prices are at 1,757.45 RMB/ton, with a week-on-week decrease of 0.4% [63]. - **Vitamins**: The price of Vitamin A is reported at 61.5 RMB/kg, down 1.6% week-on-week [79]. Investment Themes - **Tire Sector**: Domestic tire companies are positioned strongly, with a focus on growth stocks [4]. - **Consumer Electronics**: Recovery in demand is anticipated, benefiting upstream material companies [4]. - **Phosphate Chemicals**: Supply constraints due to environmental policies are expected to tighten the market [4]. - **Vitamin Supply**: Supply disruptions in Vitamin A and E are noted, creating potential investment opportunities [4].

大家早上壕！ 先看海外要闻： 美股继续收涨，道指收涨0.63%、纳指收涨0.91%、标普500收涨0.55%；Meta收涨5.66%，创7月31日以来最大单日涨幅；特斯拉涨4.15%、微软、 亚马逊至少涨1.31%，英伟达、谷歌A、苹果至多涨0.83%。 美国总统特朗普谈及美联储主席人选，声称：面试已经结束，很快会公布，心中有人选。 AI需求兑现但供应将至"最低点"，英特尔Q1指引逊色，盘后大跌超10%；英伟达四季度完成对英特尔50亿美元投资。 马斯克：特斯拉将在今年底、或明年向公众销售人形机器人；在美国得州的无人驾驶出租车RoboTaxi取消安全监督员。 SpaceX计划于2027年发射星链二代卫星，瞄准5G级体验。 今年产能已售罄！日本铠侠：NAND供应紧张料至少持续至2027年。 消息称 OpenAI 低调布局人形机器人：旧金山实验室百人团队训练机械臂做家务。 Meta宣布Threads平台月活跃用户突破4亿，面向全球推出广告。 苹果扩大硬件主管职权，释放CEO候选人信号。 5400美元！高盛大幅上调黄金目标价：富豪们正跑步入场，与央行争夺"有限实物储备"。 点评：平头哥依托阿里云的场景优势缩短芯片从设 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 三、风险提示 本项目从试生产到完全达产尚需一定时间，未来还将可能面临政策调整、 市场变化、价格波动、竞争 加剧等因素的影响，存在项目效益不及预期的风险。公司将综合市场情况，客户需求等各方因素组织生 产运营，敬请广大投资者注意投资风险。 宏昌电子材料股份有限公司董事会 2026年1月23日 一、项目建设情况 宏昌电子材料股份有限公司（以下简称"公司"）向特定对象发行股票募集资金投资项目"珠海宏昌电子 材料有限公司年产8万吨电子级功能性环氧树脂项目"（以下简称"本项目"）已完成项目建设工作。 因本项目的部分产品涉及危险化学品，根据《广东省应急管理厅危险化学品建设项目安全监督管理实施 细则》等规定，本项目需要进行试生产。 近日，珠海宏昌电子材料有限公司取得珠海市应急管理局出具的《危险化学品建设项目试生产（使用） 方案备案回执》，本项目试生产（使用）期限为2026年1月21日至2026年7月20日。公司将依照国家法律 法规、标准规范规定采取各项措施，确保试生产（使用）安全。 二、对 ...

Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]

Group 1 - Huakang Clean announced it is the first candidate for the bid of the Wuhan First Hospital expansion project with a bid amount of 54.88 million yuan and a construction period of 120 days [1] - Hualing Steel's subsidiary plans to invest 449.88 million yuan in a major overhaul project for its coking plant, aiming to address aging issues and restore production capacity over a 19-month construction period [2] - Yinjia Technology expects a net loss of 140 million to 110 million yuan for 2025, compared to a loss of 129 million yuan in the previous year [3] Group 2 - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan for 2025, recovering from a loss of 58.52 million yuan in the previous year [4] - Shiyi Da anticipates a net profit increase of 31 million to 46 million yuan for 2025, turning around from a loss of 23.41 million yuan last year [5] - Lijun Co. expects a net profit of 48 million to 66 million yuan for 2025, representing a decline of 45.05% to 60.03% compared to the previous year [7] Group 3 - Xindian Pharmaceutical plans to repurchase shares worth 25 million to 50 million yuan for employee stock ownership plans or equity incentives, with a maximum repurchase price of 42 yuan per share [6] - Jingchen Co. has set the initial transfer price for its shares at 82.85 yuan per share, with a total of 13.1 million shares to be transferred to 28 institutional investors [8] - Zejing Pharmaceutical received approval for clinical trials of its innovative cancer immunotherapy drug ZG005 in combination with platinum-based chemotherapy for advanced nasopharyngeal and esophageal squamous cell carcinoma [9] Group 4 - Xingqi Eye Medicine expects a net profit of 662 million to 749 million yuan for 2025, marking a growth of 95.82% to 121.56% compared to the previous year [10] - Liancheng Precision anticipates a net loss of 12 million to 17 million yuan for 2025, reducing its loss from 37.96 million yuan in the previous year [11] - Beidou Star expects a net loss of 230 million to 290 million yuan for 2025, improving from a loss of 350 million yuan last year [13] Group 5 - Qing Shan Paper's affiliate won a bid for a wastewater treatment project worth 51.9 million yuan [15] - Yiling Pharmaceutical forecasts a net profit of 1.2 billion to 1.3 billion yuan for 2025, recovering from a loss of 725 million yuan in the previous year [16] - Huahai Pharmaceutical received a drug registration certificate for its product used in treating depression and obsessive-compulsive disorder [23] Group 6 - Nanjing Panda expects a net profit of 10 million to 15 million yuan for 2025, turning around from a loss of 189 million yuan last year [40] - Rui Sheng Intelligent anticipates a net profit of 33.92 million to 38.40 million yuan for 2025, representing a growth of 112% to 140% compared to the previous year [41] - Jiechang Drive expects a net profit of 395 million to 437 million yuan for 2025, with a growth of 40% to 55% compared to the previous year [43]

证券代码：603002 证券简称：宏昌电子 公告编号：2026-001 宏昌电子材料股份有限公司关于 全资子公司"珠海宏昌电子材料有限公司年产8万吨 电子级功能性环氧树脂项目"试生产的公告 一、项目建设情况 宏昌电子材料股份有限公司（以下简称"公司"）向特定对象发行股票募集 资金投资项目"珠海宏昌电子材料有限公司年产 8 万吨电子级功能性环氧树脂 项目"（以下简称"本项目"） 已完成项目建设工作。 因本项目的部分产品涉及危险化学品，根据《广东省应急管理厅危险化学品 建设项目安全监督管理实施细则》等规定，本项目需要进行试生产。 近日，珠海宏昌电子材料有限公司取得珠海市应急管理局出具的《危险化学 品建设项目试生产（使用）方案备案回执》，本项目试生产（使用）期限为 2026 年 1 月 21 日至 2026 年 7 月 20 日。公司将依照国家法律法规、标准规范规定采 取各项措施，确保试生产（使用）安全。 二、对公司的影响 本项目建成投产将使公司生产能力进一步提高，规模进一步扩大，进一步优 化产品结构，有助于进一步提高公司竞争力，对公司未来经营业绩产生积极的影 响。 1 三、风险提示 本公司董事会及全体董事保证本公 ...

Core Viewpoint - The article emphasizes the AIPCB wave and highlights the investment opportunities arising from the upgrade of M9 materials, focusing on four main lines of development [1]. Group 1: Low Dielectric Electronic Fabrics - The transition from LDK to second-generation fabrics is underway, with M9 paired with Q fabrics evolving towards third-generation products [17]. - The market for low dielectric electronic fabrics is expected to grow rapidly, driven by AI server demand, with a projected compound annual growth rate of 23.8% from 2024 to 2033 [20][23]. Group 2: Electronic Resins - The use of hydrocarbon resins in M9 is expected to increase significantly, with a ratio of hydrocarbon resins to PPO rising to 2:1, enhancing the value of materials [31][34]. - New types of resins are becoming mainstream, with hydrocarbon resins being the preferred choice for next-generation high-frequency CCLs [31][39]. Group 3: Fillers - The proportion of spherical silica micro-powder in M9 is expected to increase significantly, with high-performance spherical silica micro-powder filling ratios expanding to over 40% [36][40]. - Liquid-phase preparation methods for silica are becoming the industry standard, meeting the requirements for M7 and above [40]. Group 4: Other Upstream PCB Materials - Attention is drawn to electronic-grade fluorinated copper powder and PCB-specific electronic chemicals, which are essential for the upgrade trends in high-end PCBs [3][43]. - The supply of high-end materials, including Low Dk electronic fabrics and HVLP copper foil, is facing shortages, with major manufacturers accelerating production to meet demand [7][29]. Group 5: Market Performance - The demand for high-end CCL driven by AI is accelerating the upgrade of upstream materials, with significant performance improvements observed in various AIPCB sub-sectors since mid-2025 [5][8]. - The average increase in AIPCB sub-sector indices from May to August 2025 shows substantial growth, particularly in electronic fabrics and copper foil [6]. Group 6: Investment Recommendations - Companies to watch include: 1. Low dielectric electronic fabrics: Honghe Technology, Feilihua, Zhongcai Technology [4]. 2. HVLP networks: Gangguan Copper Foil, Rongfu Technology, Longyang Electronics [4]. 3. Electronic resins: Dongcai Technology, Shengnong Group, Hongchang Electronics, Tongzi New Materials [4]. 4. Other upstream materials: Jiangnan New Materials for electronic-grade oxidized copper powder, Tiancheng Technology for PCB-specific electronic chemicals [4].

Group 1 - The A-share market continues to show strength in the chemical sector, with notable stock increases including Hongbaoli up 9%, Jujiao Co. up 8%, and Rike Chemical up 6% [1] - The benchmark price for propylene oxide on January 21 is reported at 8233.33 yuan/ton, reflecting a 6.47% increase compared to the beginning of the month [1] - Over the past week (January 12 to 18), the price of propylene oxide has surged by 7.9%, leading the chemical market [1] Group 2 - Key stock performances include: - Hongbaoli with a market cap of 6.992 billion yuan and a year-to-date increase of 25.79% [2] - Jujiao Co. with a market cap of 4.897 billion yuan and a year-to-date increase of 27.46% [2] - Rike Chemical with a market cap of 3.598 billion yuan and a year-to-date increase of 15.87% [2] - Other notable stocks include Aladdin up 5.52%, Youcai Resources up 5.41%, and Qiaoyuan Co. up 5.23%, all showing strong year-to-date performance [2]

Core Viewpoint - The electronic chemicals sector experienced a significant increase of 4.9% on January 15, with Shanghai Xinyang leading the gains, while the overall Shanghai Composite Index fell by 0.33% [1]. Group 1: Market Performance - Shanghai Xinyang closed at 88.50, up 16.60%, with a trading volume of 389,100 shares and a transaction value of 3.207 billion [1]. - Nanda Optoelectronics saw a closing price of 62.75, increasing by 10.15%, with a trading volume of 1,556,000 shares [1]. - Hongchang Electronics closed at 8.19, up 8.05%, with a trading volume of 1,169,100 shares [1]. - The electronic chemicals sector's main stocks showed various increases, with notable performances from Feikai Materials and Jingrui Electric Materials, which rose by 6.94% and 6.34% respectively [1]. Group 2: Capital Flow - The electronic chemicals sector had a net inflow of 2.391 billion in main funds, while retail investors saw a net outflow of 2.183 billion [2]. - Nanda Optoelectronics had a main fund net inflow of 632 million, but retail investors experienced a net outflow of 516 million [3]. - Jingrui Electric Materials reported a main fund net inflow of 351 million, with retail investors seeing a net outflow of 477 million [3].